Get started
Author

Drake Alton

Observed name: D. Alton
OpenAlex ID: A5113150289
Abstract PS4-10-06: Analysis of Adverse Events and Outcomes of Adjuvant Therapies in TNBC as Monotherapy and Combination: Pembrolizumab, Capecitabine, and Olaparib
2026 · R. Garza-Morales, F. Raheem, et al. · Clinical Cancer Research
TMIC-113. An Alzheimer’s neuroinflammatory microenvironment resists glioblastoma immune hijacking
2025 · David Nascari, Ryan Eghlimi, et al. · Neuro-Oncology
EXTH-141. Immune Rejuvenation via Platelet Factor 4 Alters Tumor Progression in Aged Brain Cancer Models
2025 · Drake Alton, Emily Huie, et al. · Neuro-Oncology
PDF
Abstract P4-05-01: Retrospective Analysis of fam-Trastuzumab Deruxtecan Treatment in Advanced Breast Cancer Patients: Real World Experience at Mayo Clinic in Arizona (2022-2024)
2025 · Drake Alton, Somanshu Sharma, et al. · Clinical Cancer Research
Pulmonary toxicities in patients (pts) with metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd): The Mayo Clinic Enterprise Experience, updated.
2025 · Jenna Elizabeth Hoppenworth, Claire Yee, et al. · Journal of Clinical Oncology
PDF
Abstract 5562: Altered tumor microenvironment in animal model of concomitant GBM and Alzheimer's pathology
2024 · David Nascari, Ryan Eghlimi, et al. · Cancer Research
Abstract 5905: Propentofylline enhances GBM sensitivity to temozolomide via targeting TROY signaling
2024 · Ryan Eghlimi, David Nascari, et al. · Cancer Research
Works count: 7
Citation count:
H-index:
I10-index:
Year
Topic
Type